Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Nov 20, 08:56

339,865 Shares in Vir Biotechnology, Inc. $VIR Bought by Edgestream Partners L.P. - Zolmax

Vir Biotechnology Inc
Webhose 2026 Nov 19, 09:14

Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Has Average Target Price of $22.57

Vir Biotechnology Inc
Webhose 2026 Nov 17, 07:40

Vir Biotechnology (NASDAQ:VIR) Stock Price Breaks Below 200-Day Moving Average - Here's Why

Vir Biotechnology Inc
Webhose 2026 Nov 15, 12:42

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Here's Why - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Nov 13, 17:37

Vir Bio secures US$150m ahead of London healthcare conference

Vir Biotechnology Inc
Webhose 2026 Nov 13, 15:09

Vir Biotechnology Shares Fall 18% On Pricing Of $150 Mln Shares Offering

Vir Biotechnology Inc
Webhose 2026 Nov 13, 14:57

Vir Biotechnology stock tumbles on $150M share offering

Vir Biotechnology Inc
Webhose 2026 Nov 13, 06:14

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $28.00 - Zolmax

Vir Biotechnology Inc
Webhose 2026 Nov 12, 10:11

Vir Biotechnology, Inc. $VIR Stock Sold by Pictet Asset Management Holding SA - Markets Daily

Vir Biotechnology Inc
Webhose 2026 Nov 12, 06:27

Does Phase 3 Trial Success Change The Bull Case For Vir Biotechnology (VIR)?

Vir Biotechnology Inc
Webhose 2026 Nov 12, 05:11

Vir Biotechnology, Inc. $VIR Stock: Pictet Asset Management Holding SA Cuts Holdings - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Nov 11, 04:14

What is HC Wainwright's Estimate for VIR FY2026 Earnings? - Daily Political

Vir Biotechnology Inc
Webhose 2026 Nov 10, 17:36

Vir Biotechnology (NASDAQ:VIR) Stock Gets Price Target Bump from Morgan Stanley

Vir Biotechnology Inc
Webhose 2026 Nov 10, 14:12

Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48

Vir Biotechnology Inc
Webhose 2026 Nov 09, 20:07

Is Vir Biotechnology (VIR) Overvalued After Its 127% Run?

Vir Biotechnology Inc
Webhose 2026 Nov 09, 19:29

Healthcare Stocks Rally: EDSA And DCTH Jump 30%, VIR And IMVT Also Gain

Vir Biotechnology Inc
Webhose 2026 Nov 09, 19:13

Vir Biotechnology (VIR) Says Its Hepatitis Delta Therapy Met All Phase 3 Endpoints

Vir Biotechnology Inc
Webhose 2026 Nov 09, 17:31

VIR Reiterates by HC Wainwright & Co. -- Price Target Maintained

Vir Biotechnology Inc
Webhose 2026 Nov 09, 17:09

Vir hepatitis D drug succeeds in first pivotal study

Vir Biotechnology Inc
Webhose 2026 Nov 09, 17:00

HC Wainwright Reaffirms "Buy" Rating for Vir Biotechnology (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2026 Nov 09, 16:29

Vir Biotechnology Stock Jumps 14%

Vir Biotechnology Inc
Webhose 2026 Nov 09, 16:00

Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Time to Buy?

Vir Biotechnology Inc
Webhose 2026 Nov 09, 14:54

Vir Biotechnology (VIR) Stock Jumps 13% After Phase 3 Hepatitis Delta Win

Vir Biotechnology Inc
Webhose 2026 Nov 09, 13:45

Vir Stock Soars After Late-Stage Trial Win. Why Biotech Could Be

Vir Biotechnology Inc
Webhose 2026 Nov 09, 13:06

Vir Biotechnology stock jumps 22% after hepatitis delta Phase 3 trial success

Vir Biotechnology Inc
Webhose 2026 Nov 09, 05:59

VIR Stock Soars Over 10% Overnight, Eyes Best Year Ever - Hepatitis Win Sparks Buyout Buzz And Bigger Bullish Bets

Vir Biotechnology Inc
Webhose 2026 Nov 08, 21:45

Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data | Morningstar

Vir Biotechnology Inc
Webhose 2026 Nov 08, 21:15

Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta | Morningstar

Vir Biotechnology Inc
Webhose 2026 Nov 08, 02:01

Vir Biotechnology (NASDAQ:VIR) Upgraded to Buy at Wall Street Zen - Daily Political

Vir Biotechnology Inc
Webhose 2026 Nov 07, 15:15

Vir Biotechnology Stock Gets Focus As Phase 3 Hepatitis Delta Data Head To AASLD

Vir Biotechnology Inc
Webhose 2026 Nov 07, 11:23

Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50 Day Moving Average - Should You Sell?

Vir Biotechnology Inc
Webhose 2026 Nov 07, 08:17

Vir Biotechnology (NASDAQ:VIR) Upgraded at Wall Street Zen

Vir Biotechnology Inc
Webhose 2026 Nov 06, 18:20

Vir Biotechnology (NASDAQ:VIR) Hits New 52-Week High on Analyst Upgrade

Vir Biotechnology Inc
Webhose 2026 Nov 06, 18:20

Vir Biotechnology (NASDAQ:VIR) Sets New 12-Month High Following Analyst Upgrade - Zolmax

Vir Biotechnology Inc
Webhose 2026 Nov 06, 13:59

Vir Biotechnology (NASDAQ:VIR) Raised to "Hold" at Zacks Research - Zolmax

Vir Biotechnology Inc
Webhose 2026 Nov 06, 12:30

Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Zacks Research

Vir Biotechnology Inc
Webhose 2026 Nov 05, 13:12

Needham & Company LLC Issues Positive Forecast for Vir Biotechnology (NASDAQ:VIR) Stock Price

Vir Biotechnology Inc
Webhose 2026 Nov 05, 07:14

Vir Biotechnology Inc (VIR) (Q3 2026) Earnings Call Highlights: Hepatitis Delta Data on Deck ...

Vir Biotechnology Inc
Webhose 2026 Nov 05, 05:36

Narrower Losses Could Be A Game Changer For Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Nov 05, 01:17

What Vir Biotechnology (VIR) Said on Its Q3 Earnings Call - Daily Political

Vir Biotechnology Inc
Webhose 2026 Nov 04, 22:56

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Beats Expectations By $0.18 EPS

Vir Biotechnology Inc
Webhose 2026 Nov 04, 20:08

Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells $15,216.19 in Stock

Vir Biotechnology Inc
Webhose 2026 Nov 04, 15:08

Vir Biotechnology (NASDAQ:VIR) EVP Sells $26,717.70 in Stock - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Nov 04, 12:08

Vir Biotechnology (NASDAQ:VIR) Stock: Insider Verneuil Vanina De Sells 1,343 Shares - Daily Political

Vir Biotechnology Inc
Webhose 2026 Nov 03, 05:58

Head-To-Head Review: Vir Biotechnology (NASDAQ:VIR) & BioCryst Pharmaceuticals (NASDAQ:BCRX) - Daily Political

Vir Biotechnology Inc
Webhose 2026 Oct 29, 17:00

Vir Biotechnology (NASDAQ:VIR) Reaches New 52-Week High - Should You Buy?

Vir Biotechnology Inc
Webhose 2026 Oct 28, 16:00

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next?

Vir Biotechnology Inc
Webhose 2026 Oct 28, 13:15

Gilead Cancer Deal Could Be A Game Changer For Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Oct 28, 12:45

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Here's What Happened - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Oct 28, 11:41

Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday

Vir Biotechnology Inc
Webhose 2026 Oct 27, 09:00

Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50-Day Moving Average - What's Next?

Vir Biotechnology Inc
Webhose 2026 Oct 27, 00:19

Is Vir Biotechnology (VIR) Undervalued On Its Gilead Oncology Deal?

Vir Biotechnology Inc
Webhose 2026 Oct 26, 11:58

Comparing Vir Biotechnology (NASDAQ:VIR) and REGENXBIO (NASDAQ:RGNX) - Markets Daily

Vir Biotechnology Inc
Webhose 2026 Oct 25, 08:14

Vir Biotechnology, Inc. (VIR) - What Are Investment Firms Thinking About This Stock?

Vir Biotechnology Inc

VirBiotechnology news

Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Sophia Claire 2025 Jul 03, 07:35

AI Podcast: Stock Market Melt-Up Potential? Examining the Bull Run

Noah Lee 2025 Jul 03, 07:35

AI Podcast: Does the Gold-Platinum Ratio Signal Stock Market Risk?

Latest news

Show more
US Debt Ceiling in Focus
Ava Grace 2025 Oct 25, 00:00

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Emma Rose 2025 Oct 25, 00:00

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

Noah Lee 2025 Oct 25, 00:00

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Emma Rose 2025 Oct 25, 00:00

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Sophia Claire 2025 Oct 25, 00:00

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

Emma Rose 2025 Oct 25, 00:00

US Government Shutdown Threatens October Inflation Data Release

Sophia Claire 2025 Oct 24, 00:00

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

Emma Rose 2025 Oct 24, 00:00

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk

Info

Spread

0.08

Spread (%)

0.9412 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1652221696

Shares Outstanding

186270773

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.18

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Oct 26, 16:00

What is non-farm payroll (NFP): Is higher NFP good or bad?

Stocks Forex
Ghko B 2025 Oct 26, 16:00

What is crude oil trading: how to start crude oil investing with markets.com

Commodities
Ghko B 2025 Oct 26, 16:00

Crypto trading basics: What is PooCoin, should you buy PooCoin Token 2026?

Crypto CFD Trading
Trustpilot